New York, March 2022: Axiom Market Research & Consulting™ added a report on Global Induced Pluripotent Stem Cells Market which includes study on derived cell type, product, process, application, end user, and geography. The Global Induced Pluripotent Stem Cells Market was projected to grow at a CAGR of 7.32% for the forecast period 2022 to 2028. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Global Induced Pluripotent Stem Cells Market.

The growing investment in the basic level research, especially by research organizations and academic institutes in the past years has been leading to an increased understanding of the fundamental pathways through which, the induced pluripotent stem cells market implicated in the development of disease have been driving the growth of the global induced pluripotent stem cells market during the forecast period. 

The report analyses the global induced pluripotent stem cells market based on derived cell type, product, process, application, end user, and geography. By derived cell type, the global induced pluripotent stem cells market is segmented into hepatocytes, fibroblasts, keratinocytes, and amniotic cells. By product, the global induced pluripotent stem cells market is segmented into instruments/devices, automated platforms, consumables and kits, and services. By process, the global induced pluripotent stem cells market is segmented into manual and automated. By end user, the global induced pluripotent stem cells market is segmented into hospitals, research laboratories, and academic research. By applications, the global induced pluripotent stem cells market is segmented into drug development and discovery, toxicity screening and regenerative medicine. Geographically, the global induced pluripotent stem cells market is studied for the regions including North America, Europe, Asia Pacific, and Rest of the World. 

Hepatocytes derived cell types segment is expected to dominate the global induced pluripotent stem cells market

The hepatocyte-like cells (HLCs) have been derived from the human induced pluripotent stem cells (iPSCs) has been holding a great promise in the toxicological applications and also in the medicine of regeneration has been driving the growth of the global induced pluripotent stem cells market during the forecast period. 

Instruments/devices product segment is expected to dominate the global induced pluripotent stem cells market

As the biopharmaceutical industry is continuing to adapt more assays-based cell for the primary and secondary screening due to the high biological relevance and increased value of information has been driving the growth of segment in the global induced pluripotent stem cells market during the forecast period. 

Automated manual process segment is expected to dominate the global induced pluripotent stem cells market

The factors such as ability for making any cell or tissue, the body might need to be coupled with the government and private industries have been the industries that are increasing the funding and rising industry that is focusing on the different work of the research driving the growth of the segment in the global induced pluripotent stem cells market during the forecast period. 

Drug development and discovery application segment is expected to dominate the global induced pluripotent stem cells market

The stem cells are fast becoming an invaluable tool in the drug discovery process, and the stem cells are also offering the remarkable capacity for generating an unlimited source of the disease relevant cell types from which for identifying the novel molecular targets has been driving the growth of the segment in the global induced pluripotent stem cells market during the forecast period. 

Hospitals end user segment has been dominating the global induced pluripotent stem cells market

The vast majority of eye care services in low- and middle-income countries are provided in secondary or tertiary hospitals, which are principally located in urban areas, adds to the inequity in access has been driving the growth of the segment in the global induced pluripotent stem cells market during the forecast period. 

North America is expected to dominate the global induced pluripotent stem cells market

Increasing incidence of the cancer and growing research activity in the cancer and stem cells, increasing investment in the pharmaceutical R&D has been responsible for boosting the growth of the global induced pluripotent stem cells market in the region of North America during the forecast period. 

Key Players 

The key players in the global induced pluripotent stem cells market are Fujifilm Holding Corporation, Astellas Pharma Inc., Fate Therapeutics, Inc., Bristol-Myers Squibb Company, ViaCyte, Inc., Celgene Corporation, Aastrom Biosciences, Inc., Acelity Holdings, Inc., StemCells, Inc., Japan Tissue Engineering Co. Ltd. and Organogenesis Inc. among others.

Browse for More Details: https://www.axiommrc.com/product/11226-induced-pluripotent-steam-cells-market-report

Contact Us:

Ganesh Sai

United States

3 Germay Dr.Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com